ArticleAddiction & health2026
Non-Invasive Detection of Opioid Addiction through Serum Analysis Using FTIR Spectroscopy.
Article in Addiction & health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Opioid addiction is a widespread chronic disorder associated with substantial morbidity and mortality worldwide. The impact of chronic opioid use on the serum biochemical profile remains incompletely understood. This study aimed to characterize serum biochemical profiles using Fourier Transform Infrared (FTIR) spectroscopy and evaluate their ability to differentiate opioid users from healthy controls. Methods: Serum samples were obtained from control individuals (n=40) and opioid use disorder (n=30) patients. FTIR spectroscopy was performed to obtain serum spectral profiles. To evaluate spectral differences and group discrimination based on biochemical profiles, Principal Component Analysis (PCA) and Hierarchical Cluster Analysis (HCA) were applied. Findings: FTIR spectra exhibited similar peak positions but significantly different absorbance values between groups. Phospholipid (1081 and 1246 cm Conclusion: Our analysis successfully characterized serum biochemical alterations associated with opioid use disorder and effectively discriminated opioid users from healthy controls. The observed spectral differences confirmed the potential utility of FTIR spectroscopy as a rapid, minimally invasive approach for biochemical profiling and monitoring opioid-associated molecular changes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.